O Shaughnessy Asset Management LLC cut its holdings in shares of Centene Co. (NYSE:CNC - Free Report) by 71.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 72,394 shares of the company's stock after selling 178,282 shares during the period. O Shaughnessy Asset Management LLC's holdings in Centene were worth $4,386,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also bought and sold shares of the business. Stratos Wealth Partners LTD. raised its position in shares of Centene by 4.1% in the 4th quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company's stock valued at $248,000 after acquiring an additional 163 shares during the period. Capital Advisors Ltd. LLC boosted its holdings in shares of Centene by 75.3% in the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock valued at $25,000 after buying an additional 177 shares during the period. Private Trust Co. NA increased its position in shares of Centene by 23.7% during the fourth quarter. Private Trust Co. NA now owns 956 shares of the company's stock worth $58,000 after acquiring an additional 183 shares in the last quarter. Howard Capital Management Inc. raised its holdings in shares of Centene by 5.4% during the fourth quarter. Howard Capital Management Inc. now owns 3,591 shares of the company's stock worth $218,000 after acquiring an additional 184 shares during the period. Finally, Intellectus Partners LLC lifted its position in Centene by 2.8% in the 4th quarter. Intellectus Partners LLC now owns 7,224 shares of the company's stock valued at $438,000 after acquiring an additional 200 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on CNC shares. Barclays increased their target price on Centene from $91.00 to $93.00 and gave the stock an "overweight" rating in a report on Friday, December 13th. Truist Financial dropped their target price on Centene from $89.00 to $84.00 and set a "buy" rating on the stock in a research report on Friday, December 13th. Robert W. Baird upped their price target on Centene from $66.00 to $71.00 in a research report on Tuesday, February 4th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $90.00 price objective on shares of Centene in a report on Wednesday, December 11th. Finally, Oppenheimer reduced their target price on shares of Centene from $95.00 to $85.00 and set an "outperform" rating for the company in a report on Friday, December 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $79.92.
Check Out Our Latest Stock Report on Centene
Centene Stock Performance
NYSE CNC traded down $0.66 during trading on Monday, reaching $61.27. 6,153,339 shares of the company's stock were exchanged, compared to its average volume of 4,650,284. Centene Co. has a fifty-two week low of $55.03 and a fifty-two week high of $80.59. The stock has a market capitalization of $30.39 billion, a P/E ratio of 9.82, a PEG ratio of 0.80 and a beta of 0.53. The business has a 50 day moving average price of $59.63 and a 200-day moving average price of $62.06. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10.
Centene (NYSE:CNC - Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating analysts' consensus estimates of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business had revenue of $40.81 billion for the quarter, compared to analysts' expectations of $38.78 billion. During the same quarter in the prior year, the business earned $0.45 EPS. The firm's revenue for the quarter was up 3.4% on a year-over-year basis. Sell-side analysts forecast that Centene Co. will post 6.86 earnings per share for the current fiscal year.
About Centene
(
Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Articles
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
